{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T02:21:12Z","timestamp":1784168472445,"version":"3.55.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,27]],"date-time":"2023-07-27T00:00:00Z","timestamp":1690416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.mayocp.2023.07.013","type":"journal-article","created":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T09:59:18Z","timestamp":1692957558000},"page":"927-939","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry"],"prefix":"10.1016","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9460-4435","authenticated-orcid":false,"given":"Bernadette","family":"Corica","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio Francesco","family":"Romiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Proietti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide Antonio","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tze-Fan","family":"Chao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Olshansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menno V.","family":"Huisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mayocp.2023.07.013_bib1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.pcad.2013.10.016","article-title":"Overview of epidemiology and contribution of obesity to cardiovascular disease","volume":"56","author":"Bastien","year":"2014","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2023.07.013_bib2","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/eurpub\/ckx143","article-title":"Prevalence of adult overweight and obesity in 20 European countries, 2014","volume":"28","author":"Marques","year":"2018","journal-title":"Eur J Public Health"},{"issue":"1","key":"10.1016\/j.mayocp.2023.07.013_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrcardio.2017.108","article-title":"Management of cardiovascular diseases in patients with obesity","volume":"15","author":"Lavie","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2023.07.013_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.pcad.2018.07.003","article-title":"An overview and update on obesity and the obesity paradox in cardiovascular diseases","volume":"61","author":"Elagizi","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"issue":"1","key":"10.1016\/j.mayocp.2023.07.013_bib5","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCRESAHA.120.316340","article-title":"Epidemiology of atrial fibrillation in the 21st century","volume":"127","author":"Kornej","year":"2020","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.mayocp.2023.07.013_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.pcad.2016.01.008","article-title":"Obesity and prevalence of cardiovascular diseases and prognosis\u2014the obesity paradox updated","volume":"58","author":"Lavie","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"issue":"20","key":"10.1016\/j.mayocp.2023.07.013_bib7","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1093\/eurheartj\/ehv486","article-title":"The role of obesity in atrial fibrillation","volume":"37","author":"Nalliah","year":"2016","journal-title":"Eur Heart J"},{"issue":"19","key":"10.1016\/j.mayocp.2023.07.013_bib8","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.mayocp.2023.07.013_bib9","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1016\/j.jacc.2015.03.002","article-title":"Long-term effect of goal-directed weight management in an atrial fibrillation cohort: a long-term follow-up study (LEGACY)","volume":"65","author":"Pathak","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"34","key":"10.1016\/j.mayocp.2023.07.013_bib10","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.mayocp.2023.07.013_bib11","article-title":"Association between clustering of unhealthy lifestyle factors and risk of new-onset atrial fibrillation: a nationwide population-based study","volume":"10","author":"Lee","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.mayocp.2023.07.013_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.885016","article-title":"Clustering of unhealthy lifestyle and the risk of adverse events in patients with atrial fibrillation","volume":"9","author":"Lee","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"16","key":"10.1016\/j.mayocp.2023.07.013_bib13","doi-asserted-by":"crossref","first-page":"e750","DOI":"10.1161\/CIR.0000000000000748","article-title":"Lifestyle and risk factor modification for reduction of atrial fibrillation: a Scientific Statement from the American Heart Association","volume":"141","author":"Chung","year":"2020","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mayocp.2023.07.013_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nrcardio.2017.153","article-title":"The ABC pathway: an integrated approach to improve AF management","volume":"14","author":"Lip","year":"2017","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2023.07.013_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/a-1515-9630","article-title":"Adherence to the \u201cAtrial Fibrillation Better Care\u201d pathway in patients with atrial fibrillation: impact on clinical outcomes\u2014a systematic review and meta-analysis of 285,000 patients","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"},{"issue":"5","key":"10.1016\/j.mayocp.2023.07.013_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"Hindricks","year":"2021","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.mayocp.2023.07.013_bib17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1055\/s-0041-1739411","article-title":"2021 Focused Update Consensus Guidelines of the Asia Pacific Heart Rhythm Society on Stroke Prevention in Atrial Fibrillation: executive summary","volume":"122","author":"Chao","year":"2022","journal-title":"Thromb Haemost"},{"issue":"4","key":"10.1016\/j.mayocp.2023.07.013_bib18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.pcad.2015.12.003","article-title":"Update on obesity and obesity paradox in heart failure","volume":"58","author":"Lavie","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.mayocp.2023.07.013_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.pcad.2022.11.013","article-title":"Updates on obesity and the obesity paradox in cardiovascular diseases","volume":"78","author":"Tutor","year":"2023","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2023.07.013_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40256-019-00374-0","article-title":"Obesity paradox in atrial fibrillation: implications for outcomes and relationship with oral anticoagulant drugs","volume":"20","author":"Proietti","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"issue":"7","key":"10.1016\/j.mayocp.2023.07.013_bib21","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.amjmed.2009.11.026","article-title":"Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox","volume":"123","author":"Badheka","year":"2010","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.mayocp.2023.07.013_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ajcn\/4.1.20","article-title":"The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease","volume":"4","author":"Vague","year":"1956","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.mayocp.2023.07.013_bib23","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2017.07.763","article-title":"Metabolically healthy obese and incident cardiovascular disease events among 3.5 million men and women","volume":"70","author":"Caleyachetty","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.mayocp.2023.07.013_bib24","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1111\/dom.14492","article-title":"Metabolically healthy obesity and cardiovascular events: a nationwide cohort study","volume":"23","author":"Fauchier","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"13","key":"10.1016\/j.mayocp.2023.07.013_bib25","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/j.jacc.2018.08.1037","article-title":"Healthy weight and obesity prevention: JACC Health Promotion Series","volume":"72","author":"Lavie","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.mayocp.2023.07.013_bib26","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1053\/meta.2001.27213","article-title":"Are there persons who are obese, but metabolically healthy?","volume":"50","author":"Sims","year":"2001","journal-title":"Metabolism"},{"issue":"2","key":"10.1016\/j.mayocp.2023.07.013_bib27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","article-title":"Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans","volume":"26","author":"Stefan","year":"2017","journal-title":"Cell Metab"},{"issue":"11","key":"10.1016\/j.mayocp.2023.07.013_bib28","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","article-title":"Are metabolically healthy overweight and obesity benign conditions? A systematic review and meta-analysis","volume":"159","author":"Kramer","year":"2013","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.mayocp.2023.07.013_bib29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ahj.2013.12.006","article-title":"Design and rationale of Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation: a global registry program on long-term oral antithrombotic treatment in patients with atrial fibrillation","volume":"167","author":"Huisman","year":"2014","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.mayocp.2023.07.013_bib30","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1007\/s00392-021-01957-1","article-title":"Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry","volume":"111","author":"Huisman","year":"2022","journal-title":"Clin Res Cardiol"},{"issue":"5","key":"10.1016\/j.mayocp.2023.07.013_bib31","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1007\/s00392-022-01996-2","article-title":"Comparative effectiveness and safety of non\u2013vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry","volume":"111","author":"Lip","year":"2022","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.mayocp.2023.07.013_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ahj.2019.08.012","article-title":"Safety and effectiveness of dabigatran at 2 years: final outcomes from Phase II of the GLORIA-AF registry program","volume":"218","author":"Mazurek","year":"2019","journal-title":"Am Heart J"},{"issue":"7","key":"10.1016\/j.mayocp.2023.07.013_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S2213-8587(21)00088-7","article-title":"Ethnicity-specific BMI cutoffs for obesity based on type 2 diabetes risk in England: a population-based cohort study","volume":"9","author":"Caleyachetty","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"9536","key":"10.1016\/j.mayocp.2023.07.013_bib35","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0140-6736(06)69251-9","article-title":"Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies","volume":"368","author":"Romero-Corral","year":"2006","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.mayocp.2023.07.013_bib36","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1136\/heartjnl-2012-303066","article-title":"Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease","volume":"99","author":"Azimi","year":"2013","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.mayocp.2023.07.013_bib37","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1471-2458-14-14","article-title":"Beyond BMI: the \u201cmetabolically healthy obese\u201d phenotype & its association with clinical\/subclinical cardiovascular disease and all-cause mortality\u2014a systematic review","volume":"14","author":"Roberson","year":"2014","journal-title":"BMC Public Health"},{"issue":"12","key":"10.1016\/j.mayocp.2023.07.013_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13127","article-title":"Metabolically healthy overweight\/obesity are associated with increased risk of cardiovascular disease in adults, even in the absence of metabolic risk factors: a systematic review and meta-analysis of prospective cohort studies","volume":"21","author":"Opio","year":"2020","journal-title":"Obes Rev"},{"issue":"5","key":"10.1016\/j.mayocp.2023.07.013_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.8860","article-title":"Metabolically healthy obesity redefined","volume":"4","author":"April-Sanders","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.mayocp.2023.07.013_bib40","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.amjcard.2016.04.013","article-title":"Relation of nonvalvular atrial fibrillation to body mass index (from the SPORTIF Trials)","volume":"118","author":"Proietti","year":"2016","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2023.07.013_bib41","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jacep.2015.12.001","article-title":"Association of body mass index with care and outcomes in patients with atrial fibrillation: results from the ORBIT-AF registry","volume":"2","author":"Pandey","year":"2016","journal-title":"JACC Clin Electrophysiol"},{"issue":"9","key":"10.1016\/j.mayocp.2023.07.013_bib42","article-title":"Relation of body mass index with adverse outcomes among patients with atrial fibrillation: a meta-analysis and systematic review","volume":"5","author":"Zhu","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.mayocp.2023.07.013_bib43","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejim.2020.04.032","article-title":"Influence of BMI and geographical region on prescription of oral anticoagulants in newly diagnosed atrial fibrillation: the GLORIA-AF Registry Program","volume":"80","author":"Boriani","year":"2020","journal-title":"Eur J Intern Med"},{"issue":"1","key":"10.1016\/j.mayocp.2023.07.013_bib44","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12872-016-0310-7","article-title":"Prolonged and intensive medication use are associated with the obesity paradox after percutaneous coronary intervention: a systematic review and meta-analysis of 12 studies","volume":"16","author":"Tan","year":"2016","journal-title":"BMC Cardiovasc Disord"},{"issue":"9","key":"10.1016\/j.mayocp.2023.07.013_bib45","doi-asserted-by":"crossref","first-page":"780","DOI":"10.4065\/84.9.780","article-title":"The association between cardiorespiratory fitness and risk of all-cause mortality among women with impaired fasting glucose or undiagnosed diabetes mellitus","volume":"84","author":"Lyerly","year":"2009","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.mayocp.2023.07.013_bib46","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jacc.2022.05.031","article-title":"Cardiorespiratory fitness and mortality risk across the spectra of age, race, and sex","volume":"80","author":"Kokkinos","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.mayocp.2023.07.013_bib47","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/j.jacc.2022.05.030","article-title":"Fit is it for longevity across populations","volume":"80","author":"Lavie","year":"2022","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.mayocp.2023.07.013_bib48","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.jacc.2023.02.004","article-title":"It\u2019s time to (again) recognize the considerable clinical and public health significance of cardiorespiratory fitness","volume":"81","author":"Kaminsky","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.mayocp.2023.07.013_bib49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pcad.2018.07.004","article-title":"The joint association of fitness and fatness on cardiovascular disease mortality: a meta-analysis","volume":"61","author":"Barry","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2023.07.013_bib50","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.pcad.2018.07.008","article-title":"Role of physical activity and fitness in the characterization and prognosis of the metabolically healthy obesity phenotype: a systematic review and meta-analysis","volume":"61","author":"Ortega","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"issue":"10","key":"10.1016\/j.mayocp.2023.07.013_bib51","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association Practical Guide on the use of non\u2013vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"issue":"9403","key":"10.1016\/j.mayocp.2023.07.013_bib52","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"Nishida","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.mayocp.2023.07.013_bib53","article-title":"Adherence to the Atrial Fibrillation Better Care (ABC) pathway and the risk of major outcomes in patients with atrial fibrillation: a post-hoc analysis from the prospective GLORIA-AF Registry","volume":"55","author":"Romiti","year":"2022","journal-title":"EClinicalMedicine"},{"issue":"12","key":"10.1016\/j.mayocp.2023.07.013_bib54","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1055\/s-0042-1756355","article-title":"Clinical complexity domains, anticoagulation, and outcomes in patients with atrial fibrillation: a report from the GLORIA-AF Registry Phase II and III","volume":"122","author":"Romiti","year":"2022","journal-title":"Thromb Haemost"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619623003476?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619623003476?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T09:58:11Z","timestamp":1717495091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619623003476"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0025619623003476"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.07.013","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes in Metabolically Healthy and Unhealthy Obese and Overweight Patients With Atrial Fibrillation: Findings From the GLORIA-AF Registry","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2023.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc on behalf of Mayo Foundation for Medical Education and Research.","name":"copyright","label":"Copyright"}]}}